Top Key Companies for Precision Oncology Market: Acrivon Therapeutics, Bio-Serv, Exact Sciences Corporation, Illumina, Inc., Invitae Corporation, Laboratory Corporation of America, QIAGEN, Rain Oncology, Relay Therapeutics, Strata Oncology, Inc., Thermo Fisher Scientific Inc., Variantyx, Inc..
Global Precision Oncology Market Size was estimated at USD 587.9 million in 2022 and is projected to reach USD 892.22 million by 2028, exhibiting a CAGR of 7.2% during the forecast period.
Global Precision Oncology Market Overview And Scope:
The Global Precision Oncology Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Precision Oncology utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Precision Oncology Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Precision Oncology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Precision Oncology market.
Global Precision Oncology Market Segmentation
By Type, Precision Oncology market has been segmented into:
Diagnostics
Therapeutics
By Application, Precision Oncology market has been segmented into:
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Laboratories
Healthcare Data Companies
Regional Analysis of Precision Oncology Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Precision Oncology Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Precision Oncology market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Precision Oncology market.
Top Key Companies Covered in Precision Oncology market are:
Acrivon Therapeutics
Bio-Serv
Exact Sciences Corporation
Illumina
Inc.
Invitae Corporation
Laboratory Corporation of America
QIAGEN
Rain Oncology
Relay Therapeutics
Strata Oncology
Inc.
Thermo Fisher Scientific Inc.
Variantyx
Inc.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Precision Oncology Market by Type
5.1 Precision Oncology Market Overview Snapshot and Growth Engine
5.2 Precision Oncology Market Overview
5.3 Diagnostics
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Diagnostics: Geographic Segmentation
5.4 Therapeutics
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Therapeutics: Geographic Segmentation
Chapter 6: Precision Oncology Market by Application
6.1 Precision Oncology Market Overview Snapshot and Growth Engine
6.2 Precision Oncology Market Overview
6.3 Pharmaceutical & Biotechnology Companies
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Pharmaceutical & Biotechnology Companies: Geographic Segmentation
6.4 Hospitals & Diagnostic Laboratories
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Hospitals & Diagnostic Laboratories: Geographic Segmentation
6.5 Healthcare Data Companies
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Healthcare Data Companies: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Precision Oncology Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Precision Oncology Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Precision Oncology Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 ACRIVON THERAPEUTICS
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 BIO-SERV
7.4 EXACT SCIENCES CORPORATION
7.5 ILLUMINA
7.6 INC.
7.7 INVITAE CORPORATION
7.8 LABORATORY CORPORATION OF AMERICA
7.9 QIAGEN
7.10 RAIN ONCOLOGY
7.11 RELAY THERAPEUTICS
7.12 STRATA ONCOLOGY
7.13 INC.
7.14 THERMO FISHER SCIENTIFIC INC.
7.15 VARIANTYX
7.16 INC.
Chapter 8: Global Precision Oncology Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Diagnostics
8.2.2 Therapeutics
8.3 Historic and Forecasted Market Size By Application
8.3.1 Pharmaceutical & Biotechnology Companies
8.3.2 Hospitals & Diagnostic Laboratories
8.3.3 Healthcare Data Companies
Chapter 9: North America Precision Oncology Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Diagnostics
9.4.2 Therapeutics
9.5 Historic and Forecasted Market Size By Application
9.5.1 Pharmaceutical & Biotechnology Companies
9.5.2 Hospitals & Diagnostic Laboratories
9.5.3 Healthcare Data Companies
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Precision Oncology Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Diagnostics
10.4.2 Therapeutics
10.5 Historic and Forecasted Market Size By Application
10.5.1 Pharmaceutical & Biotechnology Companies
10.5.2 Hospitals & Diagnostic Laboratories
10.5.3 Healthcare Data Companies
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Precision Oncology Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Diagnostics
11.4.2 Therapeutics
11.5 Historic and Forecasted Market Size By Application
11.5.1 Pharmaceutical & Biotechnology Companies
11.5.2 Hospitals & Diagnostic Laboratories
11.5.3 Healthcare Data Companies
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Precision Oncology Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Diagnostics
12.4.2 Therapeutics
12.5 Historic and Forecasted Market Size By Application
12.5.1 Pharmaceutical & Biotechnology Companies
12.5.2 Hospitals & Diagnostic Laboratories
12.5.3 Healthcare Data Companies
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Precision Oncology Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Diagnostics
13.4.2 Therapeutics
13.5 Historic and Forecasted Market Size By Application
13.5.1 Pharmaceutical & Biotechnology Companies
13.5.2 Hospitals & Diagnostic Laboratories
13.5.3 Healthcare Data Companies
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Precision Oncology Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Diagnostics
14.4.2 Therapeutics
14.5 Historic and Forecasted Market Size By Application
14.5.1 Pharmaceutical & Biotechnology Companies
14.5.2 Hospitals & Diagnostic Laboratories
14.5.3 Healthcare Data Companies
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Precision Oncology Scope:
|
Report Data
|
Precision Oncology Market
|
|
Precision Oncology Market Size in 2025
|
USD XX million
|
|
Precision Oncology CAGR 2025 - 2032
|
XX%
|
|
Precision Oncology Base Year
|
2024
|
|
Precision Oncology Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Acrivon Therapeutics, Bio-Serv, Exact Sciences Corporation, Illumina, Inc., Invitae Corporation, Laboratory Corporation of America, QIAGEN, Rain Oncology, Relay Therapeutics, Strata Oncology, Inc., Thermo Fisher Scientific Inc., Variantyx, Inc..
|
|
Key Segments
|
By Type
Diagnostics
Therapeutics
By Applications
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Laboratories
Healthcare Data Companies
|
